Immunogen Inc. (IMGN) Posts Q3 EPS Loss of $0.22
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
SYBX, DSGN, ATRA, More
EPS Growth %: +100.0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
SYBX, DSGN, ATRA, More
Join SI Premium – FREE
Immunogen Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $4.19 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- XPeng (XPEV) posts better-than-expected earnings, margin for Q4; stock climbs
- DLocal Limited (DLO) Misses Q4 EPS by 5c, offers outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!